CD4 and experimental autoimmune encephalomyelitis: In another study, Themis has been shown to modulate the severity of experimental autoimmune encephalomyelitis (EAE) by regulating TCR-independent signaling and the production of pro-inflammatory cytokines in CD4+ T cells, mainly polarized TH1 cells (64).